Heiko van der Kuip

3.8k total citations
60 papers, 2.8k citations indexed

About

Heiko van der Kuip is a scholar working on Oncology, Molecular Biology and Hematology. According to data from OpenAlex, Heiko van der Kuip has authored 60 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Oncology, 26 papers in Molecular Biology and 22 papers in Hematology. Recurrent topics in Heiko van der Kuip's work include Chronic Myeloid Leukemia Treatments (21 papers), Chronic Lymphocytic Leukemia Research (13 papers) and Cancer-related Molecular Pathways (13 papers). Heiko van der Kuip is often cited by papers focused on Chronic Myeloid Leukemia Treatments (21 papers), Chronic Lymphocytic Leukemia Research (13 papers) and Cancer-related Molecular Pathways (13 papers). Heiko van der Kuip collaborates with scholars based in Germany, United States and Israel. Heiko van der Kuip's co-authors include Walter E. Aulitzky, Matthias Gutekunst, Matthias Schwab, Justus Duyster, Moshe Oren, John A. Hickman, Martin F. Fromm, Siegfried Drescher, Cornelius Miething and Suzana Vidic and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Blood and PLoS ONE.

In The Last Decade

Heiko van der Kuip

60 papers receiving 2.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Heiko van der Kuip Germany 30 1.3k 1.0k 462 384 326 60 2.8k
Martha P. Mims United States 26 1.2k 1.0× 928 0.9× 452 1.0× 267 0.7× 300 0.9× 82 2.7k
Paul J. Fielder United States 40 693 0.5× 1.8k 1.8× 347 0.8× 155 0.4× 203 0.6× 84 4.2k
Eva M. Weissinger Germany 31 623 0.5× 1.1k 1.1× 985 2.1× 390 1.0× 333 1.0× 86 3.6k
Nashat Gabrail United States 26 2.3k 1.9× 1.6k 1.6× 828 1.8× 388 1.0× 394 1.2× 154 4.4k
Stefan Nagel Germany 31 721 0.6× 1.3k 1.3× 592 1.3× 186 0.5× 247 0.8× 125 2.9k
Xi Zhang China 32 1.8k 1.4× 1.8k 1.8× 1.4k 3.1× 385 1.0× 631 1.9× 274 4.6k
E. Thiel Germany 28 646 0.5× 698 0.7× 625 1.4× 72 0.2× 352 1.1× 121 2.5k
Jae Hong Seo South Korea 27 1.6k 1.3× 859 0.9× 190 0.4× 177 0.5× 168 0.5× 142 3.1k
Frank Gieseler Germany 28 1.3k 1.0× 1.1k 1.0× 273 0.6× 80 0.2× 173 0.5× 97 2.6k
Lan Coffman United States 21 811 0.6× 844 0.8× 848 1.8× 116 0.3× 592 1.8× 48 2.8k

Countries citing papers authored by Heiko van der Kuip

Since Specialization
Citations

This map shows the geographic impact of Heiko van der Kuip's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Heiko van der Kuip with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Heiko van der Kuip more than expected).

Fields of papers citing papers by Heiko van der Kuip

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Heiko van der Kuip. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Heiko van der Kuip. The network helps show where Heiko van der Kuip may publish in the future.

Co-authorship network of co-authors of Heiko van der Kuip

This figure shows the co-authorship network connecting the top 25 collaborators of Heiko van der Kuip. A scholar is included among the top collaborators of Heiko van der Kuip based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Heiko van der Kuip. Heiko van der Kuip is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Arandkar, Sharathchandra, Noa Furth, Nishanth Belugali Nataraj, et al.. (2018). Altered p53 functionality in cancer-associated fibroblasts contributes to their cancer-supporting features. Proceedings of the National Academy of Sciences. 115(25). 6410–6415. 93 indexed citations
2.
Heine, Simon, Michael A. Dengler, Markus Kleih, et al.. (2017). Cyclin D1 Driven CDK4 Activity Is Responsible for Hypersensitivity to NOXA Inducing Combination Treatment in Mantle Cell Lymphoma (MCL) Cells. Blood. 130. 2811–2811. 1 indexed citations
3.
Schwab, Matthias, Christoph Ulmer, Simon Heine, et al.. (2016). Hyperthermia Synergizes with Chemotherapy by Inhibiting PARP1-Dependent DNA Replication Arrest. Cancer Research. 76(10). 2868–2875. 60 indexed citations
4.
5.
Davies, Emma Jane, Meng Dong, Matthias Gutekunst, et al.. (2015). Capturing complex tumour biology in vitro: histological and molecular characterisation of precision cut slices. Scientific Reports. 5(1). 17187–17187. 92 indexed citations
6.
Hickman, John A., Ralph Graeser, Ronald De Hoogt, et al.. (2014). Three‐dimensional models of cancer for pharmacology and cancer cell biology: Capturing tumor complexity in vitro/ex vivo. Biotechnology Journal. 9(9). 1115–1128. 282 indexed citations
7.
Gutekunst, Matthias, Thomas Mueller, Michael A. Dengler, et al.. (2013). Cisplatin Hypersensitivity of Testicular Germ Cell Tumors Is Determined by High Constitutive Noxa Levels Mediated by Oct-4. Cancer Research. 73(5). 1460–1469. 47 indexed citations
8.
Nies, Anne T., Elke Schaeffeler, Heiko van der Kuip, et al.. (2013). Cellular Uptake of Imatinib into Leukemic Cells Is Independent of Human Organic Cation Transporter 1 (OCT1). Clinical Cancer Research. 20(4). 985–994. 52 indexed citations
9.
Dong, Meng, Godehard Friedel, Andreas Grabner, et al.. (2012). Cancer Cells Cue the p53 Response of Cancer-Associated Fibroblasts to Cisplatin. Cancer Research. 72(22). 5824–5832. 24 indexed citations
10.
Yılmaz, Ali, Michael A. Dengler, Heiko van der Kuip, et al.. (2012). Imaging of myocardial infarction using ultrasmall superparamagnetic iron oxide nanoparticles: a human study using a multi-parametric cardiovascular magnetic resonance imaging approach. European Heart Journal. 34(6). 462–475. 118 indexed citations
11.
Mürdter, Thomas E., et al.. (2010). Dasatinib reverses Cancer-associated Fibroblasts (CAFs) from primary Lung Carcinomas to a Phenotype comparable to that of normal Fibroblasts. Molecular Cancer. 9(1). 168–168. 62 indexed citations
12.
13.
Kuip, Heiko van der, et al.. (2009). Marker-free cell discrimination by holographic optical tweezers. Journal of the European Optical Society Rapid Publications. 4. 9028–9028. 11 indexed citations
14.
Sonnenberg, Maike, et al.. (2008). Pharmacological inhibition of c-Abl compromises genetic stability and DNA repair in Bcr-Abl-negative cells. Oncogene. 27(31). 4380–4384. 17 indexed citations
15.
Sonnenberg, Maike, Heiko van der Kuip, Péter Fritz, et al.. (2008). Highly variable response to cytotoxic chemotherapy in carcinoma-associated fibroblasts (CAFs) from lung and breast. BMC Cancer. 8(1). 364–364. 52 indexed citations
16.
Kuip, Heiko van der, Thomas E. Mürdter, Maike Sonnenberg, et al.. (2006). Short term culture of breast cancer tissues to study the activity of the anticancer drug taxol in an intact tumor environment. BMC Cancer. 6(1). 86–86. 85 indexed citations
17.
Hartmann, Ulrike, Stefan Balabanov, Patrick Ziegler, et al.. (2005). Telomere length and telomerase activity in the BCR-ABL-transformed murine Pro-B cell line BaF3 is unaffected by treatment with imatinib. Experimental Hematology. 33(5). 542–549. 9 indexed citations
18.
Alscher, Mark Dominik, Dagmar Biegger, Thomas Mettang, et al.. (2003). Apoptosis of Mesothelial Cells Caused by Unphysiological Characteristics of Peritoneal Dialysis Fluids. Artificial Organs. 27(11). 1035–1040. 13 indexed citations
19.
Jonuleit, Tarja, et al.. (2000). The tyrosine kinase inhibitor CGP 57148 (ST1 571) induces apoptosis in BCR-ABL-positive cells by down-regulating BCL-X.. PubMed. 6(5). 1958–68. 69 indexed citations
20.
Kuip, Heiko van der, et al.. (1999). The DNA-binding subunit p140 of replication factor C is upregulated in cycling cells and associates with G 1 phase cell cycle regulatory proteins. Journal of Molecular Medicine. 77(4). 386–392. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Martha P. Mims Breakdown of academic impact, for papers by Paul J. Fielder Breakdown of academic impact, for papers by Eva M. Weissinger Breakdown of academic impact, for papers by Nashat Gabrail Breakdown of academic impact, for papers by Stefan Nagel Breakdown of academic impact, for papers by Xi Zhang Breakdown of academic impact, for papers by E. Thiel Breakdown of academic impact, for papers by Jae Hong Seo Breakdown of academic impact, for papers by Frank Gieseler Breakdown of academic impact, for papers by Lan Coffman
Rankless by CCL
2026